Scribe Therapeutics Raises $128.7M in Upsized IPO
Scribe Therapeutics has priced its upsized initial public offering at $15 per share, raising a total of $128.7 million. The company is set to trade on Nasdaq under the ticker symbol SCRX.
Topics: Biotech Initial Public Offering